ConductScience.org, home

Library / Genes

CD5: CD5 molecule

1 protein, 62 patents, 2 drugs, 0 trials, 4,752 NIH grants and 18,112 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCD5HGNC
NameCD5 moleculeHGNC
NCBI Gene ID921NCBI Gene
HGNC IDHGNC:1685HGNC
EnsemblENSG00000110448NCBI Gene
AliasesLEU1, T1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P06127T-cell surface glycoprotein CD54954Ensembl, GeneID, HGNCUniProt

Patents 62

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4661970 A12025-12-1762144P06127Espacenet
EP 4650780 A22025-11-196756P06127Espacenet
EP 4641201 A22025-10-296535P06127Espacenet
JP 2025160215 A2025-10-2248P06127Espacenet
JP 2025147176 A2025-10-062371P06127Espacenet
JP 2025131704 A2025-09-09312P06127Espacenet
JP 2025529142 A2025-09-04822P06127Espacenet
JP 2025529142 A2025-09-045783P06127Espacenet
US 12371689 B22025-07-295783P06127Espacenet
US 12371689 B22025-07-29822P06127Espacenet

Drugs 2

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
TELIMOMAB ARITOXCHEMBL2108790T-cell surface glycoprotein CD5 binding agentBINDING AGENTChEMBL
ZOLIMOMAB ARITOXCHEMBL2108785T-cell surface glycoprotein CD5 binding agentBINDING AGENTChEMBL

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4752

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant1472,025NIH's project files
P30CA008748Cancer Center Support Grant972,025NIH's project files
ZIASC000550Lymphoma Disease Discovery and Definition412,025NIH's project files
ZIABC011070Hematopathology Diagnosis372,025NIH's project files
P30CA016058Cancer Center Support Grant362,025NIH's project files
ZIAHL002346Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy312,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)292,025NIH's project files
ZICSC009372Flow cytometric analysis of benign and malignant tumors242,025NIH's project files
ZIEBC011241Hematopathology Fellowship242,025NIH's project files
P30CA006973Regional Oncology Research Center232,025NIH's project files

Papers 18112

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42822732PubTator, text miningPubMed
42819318PubTator, text miningPubMed
42814322PubTator, text miningPubMed
42813173PubTator, text miningPubMed
42813078PubTator, text miningPubMed
42811949PubTator, text miningPubMed
42804794PubTator, text miningPubMed
42799861PubTator, text miningPubMed
42782044PubTator, text miningPubMed
42776811PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license